{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:43:24Z","timestamp":1791848604877,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.vaccine.2012.05.090","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T02:56:08Z","timestamp":1354244168000},"page":"F1-F11","source":"Crossref","is-referenced-by-count":42,"special_numbering":"S5","title":["Reframing Cervical Cancer Prevention. Expanding the Field Towards Prevention of Human Papillomavirus Infections and Related Diseases"],"prefix":"10.1016","volume":"30","author":[{"given":"F. Xavier","family":"Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Tsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Vorsters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2012.05.090_bib0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"The global burden of cancers attributable to infections in the year 2008","volume":"13","author":"Martel","year":"2012","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.090_bib0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.vaccine.2012.05.090_bib0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-642-78487-3_8","article-title":"Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types","volume":"186","author":"zur Hausen","year":"1994","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2012.05.090_bib0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens. B. Biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.vaccine.2012.05.090_bib0025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"issue":"Suppl 10","key":"10.1016\/j.vaccine.2012.05.090_bib0030","doi-asserted-by":"crossref","first-page":"K17","DOI":"10.1016\/j.vaccine.2008.06.021","article-title":"Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions","volume":"26","author":"Giuliano","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2012.05.090_bib0035","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.090_bib0040","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10552-008-9276-9","article-title":"Systematic review of human papillomavirus prevalence in invasive penile cancer","volume":"20","author":"Backes","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"Suppl 12","key":"10.1016\/j.vaccine.2012.05.090_bib0045","doi-asserted-by":"crossref","first-page":"M89","DOI":"10.1016\/j.vaccine.2008.06.020","article-title":"Recommendations for cervical cancer prevention in Asia Pacific","volume":"26","author":"Garland","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2012.05.090_bib0050","article-title":"Chapter 5: Updating the natural history of HPV and anogenital cancer","volume":"24","author":"Moscicki","year":"2006","journal-title":"Vaccine"},{"issue":"S5","key":"10.1016\/j.vaccine.2012.05.090_bib0330","doi-asserted-by":"crossref","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","article-title":"Updating the natural history of human papillomavirus and anogenital cancers","volume":"30","author":"Moscicki","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl 10","key":"10.1016\/j.vaccine.2012.05.090_bib0060","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2012.05.090_bib0065","article-title":"Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl 12","key":"10.1016\/j.vaccine.2012.05.090_bib0070","doi-asserted-by":"crossref","first-page":"M43","DOI":"10.1016\/j.vaccine.2008.05.005","article-title":"Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal","volume":"26","author":"Sankaranarayanan","year":"2008","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2012.05.090_bib0075","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1470-2045(08)70210-9","article-title":"A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China","volume":"9","author":"Qiao","year":"2008","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.vaccine.2012.05.090_bib0080","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"issue":"9806","key":"10.1016\/j.vaccine.2012.05.090_bib0085","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0140-6736(11)61522-5","article-title":"Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial","volume":"378","author":"Lazcano-Ponce","year":"2011","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2012.05.090_bib0090","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S1386-6532(09)70007-1","article-title":"Analytical characterization of the APTIMA HPV Assay","volume":"45","author":"Dockter","year":"2009","journal-title":"J Clin Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2012.05.090_bib0095","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","article-title":"Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears","volume":"17","author":"Szarewski","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.090_bib0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 Dual-stained cytology","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"Suppl 10","key":"10.1016\/j.vaccine.2012.05.090_bib0105","doi-asserted-by":"crossref","first-page":"K53","DOI":"10.1016\/j.vaccine.2008.06.002","article-title":"An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results","volume":"26","author":"Schiller","year":"2008","journal-title":"Vaccine"},{"issue":"S5","key":"10.1016\/j.vaccine.2012.05.090_bib0335","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A review of clinical trials of human papillomavirus prophylactic vaccines","volume":"30","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2012.05.090_bib0115","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.090_bib0120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Munoz","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.090_bib0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.vaccine.2012.05.090_bib0130","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.vaccine.2012.05.090_bib0135","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1517\/14656566.2011.596527","article-title":"Human papillomavirus: science and technologies for the elimination of cervical cancer","volume":"12","author":"Bosch","year":"2011","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.090_bib0140","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.arcmed.2009.06.003","article-title":"The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change","volume":"40","author":"Franco","year":"2009","journal-title":"Arch Med Res"},{"issue":"11","key":"10.1016\/j.vaccine.2012.05.090_bib0145","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/jnci\/djp119","article-title":"Broad-spectrum human papillomavirus vaccines: new horizons but one step at a time","volume":"101","author":"Bosch","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2012.05.090_bib0150","unstructured":"European Centre for Disease Prevention and Control (ECDC). Guidance for the introduction of HPV vaccines European countries, 2008."},{"issue":"12","key":"10.1016\/j.vaccine.2012.05.090_bib0155","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2012.05.090_bib0160","first-page":"11","article-title":"Cancer in Asia - Incidence rates based on data in cancer incidence in five continents IX (1998-2002)","volume":"11","author":"Shin","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.vaccine.2012.05.090_bib0165","unstructured":"Human papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec 2009;84(15):118\u201331."},{"issue":"2 Suppl","key":"10.1016\/j.vaccine.2012.05.090_bib0170","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.ygyno.2010.01.029","article-title":"Global implementation of human papillomavirus (HPV) vaccine: lessons from hepatitis B vaccine","volume":"117","author":"Kane","year":"2010","journal-title":"Gynecol. Oncol"},{"issue":"35","key":"10.1016\/j.vaccine.2012.05.090_bib0175","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1016\/j.vaccine.2007.06.053","article-title":"Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention","volume":"25","author":"Esposito","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2012.05.090_bib0180","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J","article-title":"Hepatitis B virus. The major etiology of hepatocellular carcinoma","volume":"61","author":"Beasley","year":"1988","journal-title":"Cancer"},{"issue":"9160","key":"10.1016\/j.vaccine.2012.05.090_bib0185","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(98)09148-X","article-title":"Hepatocellular carcinoma","volume":"353","author":"Schafer","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.090_bib0190","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"1337","key":"10.1016\/j.vaccine.2012.05.090_bib0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1098\/rspb.1993.0102","article-title":"The influence of age on the development of the hepatitis B carrier state","volume":"253","author":"Edmunds","year":"1993","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.vaccine.2012.05.090_bib0200","unstructured":"Hepatitis B vaccines. Wkly Epidemiol Rec 2009;84(40):405-19."},{"key":"10.1016\/j.vaccine.2012.05.090_bib0205","unstructured":"WHO Global Advisory Committee on Vaccine Safety. Hepatitis B, 2011. Available at: http:\/\/www.who.int\/vaccine_safety\/topics\/hepatitisb\/en\/index.html (last accessed May 2012)."},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.090_bib0210","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/cid\/cir270","article-title":"Hepatitis B and the need for a booster dose","volume":"53","author":"Leuridan","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2012.05.090_bib0215","doi-asserted-by":"crossref","first-page":"A46","DOI":"10.1016\/j.vaccine.2008.10.085","article-title":"Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence","volume":"27","author":"Bonanni","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.090_bib0220","unstructured":"World Health Organization. Sixty-third World Health Assembly: Viral hepatitis, WHA 63.18, May 2010. Available at: http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA63\/A63_r18-en.pdf (last accessed May 2012)."},{"issue":"7086","key":"10.1016\/j.vaccine.2012.05.090_bib0225","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/bmj.314.7086.1033","article-title":"Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board","volume":"314","author":"Van Damme","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2012.05.090_bib0230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/epirev\/mxj009","article-title":"Hepatitis B virus infection: epidemiology and vaccination","volume":"28","author":"Shepard","year":"2006","journal-title":"Epidemiol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.090_bib0235","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jhep.2009.01.002","article-title":"Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B","volume":"50","author":"Chen","year":"2009","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.vaccine.2012.05.090_bib0240","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1086\/503433","article-title":"Long-term protection against carriage of hepatitis B virus after infant vaccination","volume":"193","author":"van der Sande","year":"2006","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.090_bib0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00430-004-0231-4","article-title":"Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia","volume":"194","author":"Ng","year":"2005","journal-title":"Med Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.090_bib0250","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/hep.24442","article-title":"Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program","volume":"54","author":"McMahon","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.090_bib0255","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1542\/peds.2006-0724","article-title":"Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination","volume":"118","author":"Perz","year":"2006","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2012.05.090_bib0260","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1590-8658(10)60685-8","article-title":"The worldwide impact of vaccination on the control and protection of viral hepatitis B","volume":"43","author":"Romano\u2019","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"52","key":"10.1016\/j.vaccine.2012.05.090_bib0265","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1016\/j.vaccine.2007.10.005","article-title":"Prevention and control of viral hepatitis through adolescent health programmes in Europe","volume":"25","author":"FitzSimons","year":"2007","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2012.05.090_bib0270","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2471\/BLT.11.08986","article-title":"Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries","volume":"89","author":"LaMontagne","year":"2011","journal-title":"Bull World Health Organ"},{"issue":"1 Suppl","key":"10.1016\/j.vaccine.2012.05.090_bib0275","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ygyno.2010.04.004","article-title":"Current understanding of the mechanism of HPV infection","volume":"118","author":"Schiller","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.090_bib0280","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/archpediatrics.2009.50","article-title":"Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings","volume":"163","author":"Bingham","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"44","key":"10.1016\/j.vaccine.2012.05.090_bib0285","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1016\/j.vaccine.2009.08.003","article-title":"Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings","volume":"27","author":"Biellik","year":"2009","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2012.05.090_bib0290","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1016\/j.vaccine.2011.04.108","article-title":"Limited benefit of HPV vaccination for sexually active women in developing countries","volume":"29","author":"Tsu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.090_bib0295","unstructured":"PATH Rho Cervical Cancer, 2012. Available at: http:\/\/www.rho.org (last accessed May 2012)."},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.090_bib0300","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1071\/SH10018","article-title":"A brief history of economic evaluation for human papillomavirus vaccination policy","volume":"7","author":"Beutels","year":"2010","journal-title":"Sex Health"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.090_bib0305","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/djn025","article-title":"Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers","volume":"100","author":"Gillison","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"32","key":"10.1016\/j.vaccine.2012.05.090_bib0310","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.090_bib0315","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0020-7292(07)60011-3","article-title":"HPV infection and HPV-associated neoplasia in immunocompromised women","volume":"94","author":"Palefsky","year":"2006","journal-title":"Int J Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.090_bib0320","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/QAI.0b013e31817aebfe","article-title":"Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study","volume":"48","author":"D'Souza","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.090_bib0325","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","article-title":"Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data","volume":"11","author":"Donovan","year":"2011","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12009528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12009528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T02:27:44Z","timestamp":1540088864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12009528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":65,"alternative-id":["S0264410X12009528"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.090","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}